Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 6 | 2025 | 695 | 1.080 |
Why?
|
| Pneumonectomy | 6 | 2025 | 116 | 0.820 |
Why?
|
| Robotic Surgical Procedures | 3 | 2025 | 162 | 0.520 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 174 | 0.430 |
Why?
|
| Frailty | 2 | 2022 | 125 | 0.310 |
Why?
|
| Esophagectomy | 3 | 2024 | 48 | 0.290 |
Why?
|
| Retrospective Studies | 10 | 2025 | 6741 | 0.270 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 21 | 0.250 |
Why?
|
| Pheochromocytoma | 1 | 2006 | 31 | 0.250 |
Why?
|
| Conversion to Open Surgery | 1 | 2025 | 14 | 0.230 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2025 | 61 | 0.220 |
Why?
|
| Thoracic Surgery | 2 | 2025 | 76 | 0.220 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2025 | 42 | 0.220 |
Why?
|
| Resuscitation | 1 | 2025 | 74 | 0.220 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 529 | 0.220 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2025 | 128 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2025 | 856 | 0.210 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 35 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 457 | 0.200 |
Why?
|
| Esophageal Diseases | 1 | 2023 | 17 | 0.200 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 86 | 0.200 |
Why?
|
| Societies, Medical | 1 | 2025 | 381 | 0.190 |
Why?
|
| Brazil | 1 | 2021 | 100 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 28 | 0.170 |
Why?
|
| Robotics | 1 | 2022 | 87 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 423 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 531 | 0.160 |
Why?
|
| Quality Improvement | 1 | 2024 | 455 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 930 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 142 | 0.150 |
Why?
|
| Male | 12 | 2025 | 30322 | 0.150 |
Why?
|
| Humans | 19 | 2025 | 64272 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 321 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 513 | 0.140 |
Why?
|
| Aged | 10 | 2025 | 14663 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 501 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 788 | 0.130 |
Why?
|
| Female | 10 | 2025 | 33383 | 0.120 |
Why?
|
| Muscle, Smooth | 2 | 2013 | 134 | 0.110 |
Why?
|
| Bronchodilator Agents | 2 | 2013 | 119 | 0.110 |
Why?
|
| Postoperative Complications | 3 | 2025 | 1301 | 0.100 |
Why?
|
| Emergencies | 2 | 2025 | 121 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2020 | 199 | 0.100 |
Why?
|
| Middle Aged | 7 | 2025 | 17923 | 0.100 |
Why?
|
| Taste | 1 | 2013 | 39 | 0.100 |
Why?
|
| Bronchi | 1 | 2013 | 84 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 67 | 0.090 |
Why?
|
| Lymphatic Metastasis | 2 | 2007 | 93 | 0.080 |
Why?
|
| Mediastinum | 2 | 2007 | 29 | 0.080 |
Why?
|
| Calcium | 2 | 2013 | 580 | 0.080 |
Why?
|
| Ethanolamines | 1 | 2009 | 18 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 2048 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 5341 | 0.070 |
Why?
|
| Survival Rate | 2 | 2007 | 859 | 0.070 |
Why?
|
| Reoperation | 2 | 2025 | 292 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1386 | 0.070 |
Why?
|
| Etoposide | 1 | 2007 | 33 | 0.070 |
Why?
|
| Adult | 6 | 2025 | 17136 | 0.070 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 85 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2007 | 25 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 19 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 249 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2007 | 28 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 146 | 0.060 |
Why?
|
| United States | 3 | 2025 | 7923 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2006 | 74 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2006 | 154 | 0.060 |
Why?
|
| Cause of Death | 1 | 2006 | 222 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2025 | 102 | 0.060 |
Why?
|
| Propensity Score | 1 | 2025 | 167 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 5696 | 0.050 |
Why?
|
| Stomach | 1 | 2024 | 88 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 146 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 111 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2022 | 119 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 29 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 964 | 0.040 |
Why?
|
| Surgical Mesh | 1 | 2021 | 61 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 72 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1270 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 67 | 0.040 |
Why?
|
| Thoracotomy | 2 | 2013 | 47 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 652 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 340 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 240 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 1670 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 611 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 730 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 61 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 490 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 901 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 984 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2009 | 15 | 0.020 |
Why?
|
| Oscillometry | 1 | 2009 | 13 | 0.020 |
Why?
|
| Histamine | 1 | 2009 | 21 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2009 | 20 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 45 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 512 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 61 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 202 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 164 | 0.020 |
Why?
|
| Mediastinoscopy | 1 | 2007 | 8 | 0.020 |
Why?
|
| Donor Selection | 1 | 2006 | 17 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 32 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 180 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2007 | 90 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 169 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 117 | 0.020 |
Why?
|
| Graft Survival | 1 | 2006 | 297 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3449 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 587 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2006 | 302 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 358 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 487 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 20955 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1570 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4782 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 1769 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2482 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 3725 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10994 | 0.010 |
Why?
|
| Child | 1 | 2006 | 4583 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 6306 | 0.010 |
Why?
|